THE DEAL, AT A GLANCE
From the announcementIrubis
01What it doesWith the funds, Irubis plans to further expand its innovative Monipa solution, which is designed to make bioprocesses more efficient and precise.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by BioProcess360 Partners, early investors such as High-Tech Gründerfonds, Verve Ventures, Ventura BioMed InvestorsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedIrubis raised $1M Pre-Series A, announced 2026-07-21From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersIrubis is using a $1M pre-Series A round to expand Monipa, a solution described as making bioprocesses more efficient and precise.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Irubis · Financing Record
Explore source-linked visual explanations for Irubis. Unsupported claims are withheld while source review continues.
Record 9423 · Recorded date: 2026-07-21
Explore company records →